OR WAIT null SECS
© 2022 MJH Life Sciences and Applied Clinical Trials Online. All rights reserved.
© 2022 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
February 11, 2022
Six best practices and three key mistakes to avoid in new technology space.
Phase I/II study in cancer patients showcases eClinical effectiveness.
With large shift to decentralized strategies, industry roles appear set for change.
View from Brussels
2022 EU initiative provides hope for improvement of trial regulations.
From the Editor
Looking to US Medicare/Medicaid to increase patient participation.
Michael J. Hennessy, Sr., was the beloved chairman and CEO of MJH Life Sciences, parent company of Applied Clinical Trials.
Click the title above for a link to open the Applied Clinical Trials January/February 2022 issue in an interactive PDF format.
January 26, 2022
View from Washington
Uncertainty over experimental medicines calls for review of AA process.
January 11, 2022
Dr. Harish Dave, CEO of Singapore-based AUM Biosciences, discusses evolving strategies for Asian biopharmaceutical enterprises.
January 04, 2022
A Closing Thought
The need for specific capabilities to suit DCT business models is creating new challenges in team building, training, and development.
January 03, 2022
New requirements must be put in place to ensure data quality and integrity.
December 16, 2021
Optimizing feasibility through increased data collection.